Oseltamivir induced Stevens–Johnson syndrome/toxic epidermal necrolysis—case report
Authors:
Open Access
- 1 May 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 98 (19) , e15553
Abstract
Rationale: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are 2 rare but life-threatening diseases characterized by detachment of epidermis, bullous skin lesions, and mucous membrane erosions. Drugs are highly suspected to be the causative agents. We report a case of SJS/TEN induced by oseltamivir, which is a very rare event. Patient concerns: A 9-year-old girl with upper respiratory tract infections presented with generalized maculopapular rash the second day after taking oseltamivir. Diagnosis: The diagnosis of SJS/TEN was made based on cytotoxic skin lesions and mucous membrane involvement. Interventions: After discontinuing of the drug and combination therapy of corticosteroid and human immunoglobulin initiation, the lesions were improved. Human leukocyte antigen (HLA) gene sequencing was done. Outcomes: The girl was followed-up for 1 year. The skin and mucous membranes symptoms were relieved. Lessons: We report this case to attract attention to the rare but serious side effect of this antiviral drug.Keywords
This publication has 24 references indexed in Scilit:
- Intravenous immunoglobulin in the treatment of Stevens–Johnson syndrome and toxic epidermal necrolysis: a meta‐analysis with meta‐regression of observational studiesInternational Journal of Dermatology, 2014
- HLA-B*58:01 strongly associates with allopurinol-induced adverse drug reactions in a Japanese sample populationJournal of Dermatological Science, 2013
- Post-Marketing Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir: An Updated ReviewAdvances in Therapy, 2012
- Toxic epidermal necrolysis and Stevens-Johnson syndrome: A review*Critical Care Medicine, 2011
- HLA-B*5901 is Strongly Associated with Methazolamide-Induced Stevens–Johnson Syndrome/Toxic Epidermal NecrolysisPharmacogenomics, 2010
- Common Risk Allele in Aromatic Antiepileptic-Drug Induced Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Han ChinesePharmacogenomics, 2010
- Association of HLA-BFNx011502 allele and carbamazepine-inducedStevens-Johnson syndromeamong IndiansIndian Journal of Dermatology, Venereology and Leprology, 2009
- Carbamazepine, HLA-B*1502 and Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: US FDA RecommendationsPharmacogenomics, 2008
- A marker for Stevens–Johnson syndromeNature, 2004
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994